CCLA Investment Management Boosts Stake in Humana Inc. (NYSE:HUM)

CCLA Investment Management lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 1.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 316,913 shares of the insurance provider’s stock after acquiring an additional 3,227 shares during the quarter. Humana accounts for about 1.8% of CCLA Investment Management’s investment portfolio, making the stock its 26th biggest position. CCLA Investment Management owned approximately 0.26% of Humana worth $115,257,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of HUM. Vanguard Personalized Indexing Management LLC increased its holdings in Humana by 36.8% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 12,015 shares of the insurance provider’s stock worth $4,399,000 after purchasing an additional 3,229 shares during the last quarter. Tredje AP fonden increased its stake in shares of Humana by 124.2% in the second quarter. Tredje AP fonden now owns 27,253 shares of the insurance provider’s stock worth $10,183,000 after buying an additional 15,100 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. raised its holdings in Humana by 6.3% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,502 shares of the insurance provider’s stock valued at $935,000 after acquiring an additional 149 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its stake in Humana by 30.6% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 8,630 shares of the insurance provider’s stock valued at $3,224,000 after acquiring an additional 2,021 shares during the last quarter. Finally, Mutual of America Capital Management LLC grew its holdings in Humana by 1.5% during the 2nd quarter. Mutual of America Capital Management LLC now owns 19,322 shares of the insurance provider’s stock worth $7,220,000 after acquiring an additional 290 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on HUM shares. Truist Financial increased their price target on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. TD Cowen lifted their target price on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Piper Sandler initiated coverage on Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price objective on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Finally, Morgan Stanley began coverage on shares of Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 target price for the company. Thirteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $398.70.

Humana Stock Down 1.1 %

Shares of Humana stock opened at $311.85 on Wednesday. The company has a market capitalization of $37.58 billion, a P/E ratio of 19.42, a PEG ratio of 2.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The business’s fifty day moving average price is $361.77 and its two-hundred day moving average price is $346.39.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the previous year, the firm earned $8.94 EPS. Humana’s revenue was up 10.4% on a year-over-year basis. As a group, research analysts forecast that Humana Inc. will post 16 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.